| Financial Year |
March 31 2023 |
| Monetary Funds |
386,797,755.35 |
| Held-for-trading Financial Assets |
371,238,066.85 |
| Notes Receivable |
4,191,381.00 |
| Accounts Receivable |
95,687,842.33 |
| Advances to Suppliers |
16,905,940.38 |
| Other Receivables |
337,225.85 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
37,941.70 |
| Inventories |
112,864,149.32 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
215,739.99 |
| Total Current Assets |
1,028,065,176.84 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
351,632.41 |
| Investment Properties |
-- |
| Fixed Assetes |
90,207,268.70 |
| Under-construction Projects |
1,912,650.36 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
14,757,722.32 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
515,786.48 |
| Deferred Income Tax Assets |
10,470,159.19 |
| Other Non-Current Assets |
7,159,609.92 |
| Sub-Total of Non-Current Assets |
128,457,645.76 |
| Total Assets |
1,156,522,822.60 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
51,901,008.80 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
13,338,954.00 |
| Taxes Payable |
1,143,470.64 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
13,513,383.22 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
168,470.24 |
| Other Current Liabilities |
294,073.44 |
| Sub-Total of Current Liabilities |
82,666,593.42 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,054,758.71 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,839,775.21 |
| Total Liabilities |
85,506,368.63 |
| Paid-In Capital(Or Share Stock) |
237,171,371.00 |
| Capital Surplus |
826,651,528.51 |
| Surplus Reserve |
57,333,261.17 |
| LESS:Treasury Stock |
9,203,200.00 |
| Undistributed Profits |
-44,645,548.40 |
| Minority Stockholder's Interest |
3,772,619.23 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,067,243,834.74 |
| Owner's Equity（Stockholder's Equity） |
1,071,016,453.97 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,156,522,822.60 |
